Baidu
map

国家药监局综合司关于严厉打击非法制售新冠肺炎病毒检测试剂的通知

2020-03-28 国家药监局综合司 国家药监局综合司

截至3月26日,国家药监局已完成22个新型冠状病毒检测试剂盒,进一步扩大了检测试剂的供应,服务疫情防控需要。近来,出现个别未经注册的相关检测试剂产品进行虚假宣传的情况,国家药监局综合司发布相关通知。

各省、自治区、直辖市药品监督管理局,新疆生产建设兵团药品监督管理局:

新冠肺炎疫情暴发以来,国家药监局已批准22个检测试剂产品注册,不断满足疫情防控需要。近期发现,个别未经注册的相关检测试剂产品进行虚假宣传,严重扰乱市场秩序。为有效净化市场环境,切实保障公众健康权益,现就严厉打击非法制售新冠肺炎病毒检测试剂等医疗器械违法违规行为有关要求通知如下:

一、 各级药品监督管理部门要切实落实药品安全“四个最严”要求,按照《国家药监局综合司关于切实做好新型冠状病毒感染的肺炎防控用药用械质量监管工作的通知》(药监综电〔2020〕2号)等文件部署,加大对相关诊断试剂生产、经营企业、医疗器械网络交易服务第三方平台及网络销售企业监督检查力度。对违法违规线索,各级药品监督管理部门要及时组织查处,并将查处情况报送国家药监局。

二、 各级药品监督管理部门要高度重视通过网络监测、投诉举报、舆情监测、监督检查、部门通报等渠道反映的案件线索,深挖细查。对未经许可从事生产、经营活动的,生产、经营未经注册批准相关检测试剂产品的,要依法从严从快查处。对医疗器械网络第三方平台经营者未履行对入驻电商的登记核查等义务的,未对平台内相关虚假信息及时处置的,要约谈告诫并限期整改。对拒不整改或者整改不到位的,要依法严肃查处,并予以曝光。

三、各级药品监督管理部门要加强与公安、网信、通信主管等部门的协调配合,对发布虚假信息,生产销售非法新冠肺炎病毒检测试剂等产品的网站、APP等,要及时通报网信、通信主管部门;对涉嫌犯罪的,要依法及时移送公安机关。

国家药品监督管理局已批准的新冠肺炎病毒检测试剂相关信息,可通过国家药监局官方网站(http://www.nmpa.gov.cn/)动态查询。发现有违法违规行为的,请及时向12315投诉举报。

国家药监局综合司

2020年3月26日

已上市应急IVD产品汇总

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2027147, encodeId=d5ef202e147d0, content=<a href='/topic/show?id=b0bf5808689' target=_blank style='color:#2F92EE;'>#新冠肺炎病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58086, encryptionId=b0bf5808689, topicName=新冠肺炎病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c64275, createdName=piaojinhua, createdTime=Tue Feb 23 13:10:54 CST 2021, time=2021-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934660, encodeId=61e7193466056, content=<a href='/topic/show?id=325762560c5' target=_blank style='color:#2F92EE;'>#检测试剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62560, encryptionId=325762560c5, topicName=检测试剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sat Mar 13 02:10:54 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301709, encodeId=999c1301e0961, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Mon Mar 30 05:10:54 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429249, encodeId=b84814292492e, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Mon Mar 30 05:10:54 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491093, encodeId=8cd2149109315, content=<a href='/topic/show?id=db91e095978' target=_blank style='color:#2F92EE;'>#病毒检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70959, encryptionId=db91e095978, topicName=病毒检测)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Mon Mar 30 05:10:54 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027578, encodeId=b1ec102e5785a, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Mar 28 17:10:54 CST 2020, time=2020-03-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2027147, encodeId=d5ef202e147d0, content=<a href='/topic/show?id=b0bf5808689' target=_blank style='color:#2F92EE;'>#新冠肺炎病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58086, encryptionId=b0bf5808689, topicName=新冠肺炎病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c64275, createdName=piaojinhua, createdTime=Tue Feb 23 13:10:54 CST 2021, time=2021-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934660, encodeId=61e7193466056, content=<a href='/topic/show?id=325762560c5' target=_blank style='color:#2F92EE;'>#检测试剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62560, encryptionId=325762560c5, topicName=检测试剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sat Mar 13 02:10:54 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301709, encodeId=999c1301e0961, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Mon Mar 30 05:10:54 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429249, encodeId=b84814292492e, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Mon Mar 30 05:10:54 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491093, encodeId=8cd2149109315, content=<a href='/topic/show?id=db91e095978' target=_blank style='color:#2F92EE;'>#病毒检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70959, encryptionId=db91e095978, topicName=病毒检测)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Mon Mar 30 05:10:54 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027578, encodeId=b1ec102e5785a, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Mar 28 17:10:54 CST 2020, time=2020-03-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2027147, encodeId=d5ef202e147d0, content=<a href='/topic/show?id=b0bf5808689' target=_blank style='color:#2F92EE;'>#新冠肺炎病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58086, encryptionId=b0bf5808689, topicName=新冠肺炎病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c64275, createdName=piaojinhua, createdTime=Tue Feb 23 13:10:54 CST 2021, time=2021-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934660, encodeId=61e7193466056, content=<a href='/topic/show?id=325762560c5' target=_blank style='color:#2F92EE;'>#检测试剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62560, encryptionId=325762560c5, topicName=检测试剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sat Mar 13 02:10:54 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301709, encodeId=999c1301e0961, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Mon Mar 30 05:10:54 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429249, encodeId=b84814292492e, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Mon Mar 30 05:10:54 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491093, encodeId=8cd2149109315, content=<a href='/topic/show?id=db91e095978' target=_blank style='color:#2F92EE;'>#病毒检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70959, encryptionId=db91e095978, topicName=病毒检测)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Mon Mar 30 05:10:54 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027578, encodeId=b1ec102e5785a, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Mar 28 17:10:54 CST 2020, time=2020-03-28, status=1, ipAttribution=)]
    2020-03-30 xuyu
  4. [GetPortalCommentsPageByObjectIdResponse(id=2027147, encodeId=d5ef202e147d0, content=<a href='/topic/show?id=b0bf5808689' target=_blank style='color:#2F92EE;'>#新冠肺炎病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58086, encryptionId=b0bf5808689, topicName=新冠肺炎病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c64275, createdName=piaojinhua, createdTime=Tue Feb 23 13:10:54 CST 2021, time=2021-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934660, encodeId=61e7193466056, content=<a href='/topic/show?id=325762560c5' target=_blank style='color:#2F92EE;'>#检测试剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62560, encryptionId=325762560c5, topicName=检测试剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sat Mar 13 02:10:54 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301709, encodeId=999c1301e0961, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Mon Mar 30 05:10:54 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429249, encodeId=b84814292492e, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Mon Mar 30 05:10:54 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491093, encodeId=8cd2149109315, content=<a href='/topic/show?id=db91e095978' target=_blank style='color:#2F92EE;'>#病毒检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70959, encryptionId=db91e095978, topicName=病毒检测)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Mon Mar 30 05:10:54 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027578, encodeId=b1ec102e5785a, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Mar 28 17:10:54 CST 2020, time=2020-03-28, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2027147, encodeId=d5ef202e147d0, content=<a href='/topic/show?id=b0bf5808689' target=_blank style='color:#2F92EE;'>#新冠肺炎病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58086, encryptionId=b0bf5808689, topicName=新冠肺炎病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c64275, createdName=piaojinhua, createdTime=Tue Feb 23 13:10:54 CST 2021, time=2021-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934660, encodeId=61e7193466056, content=<a href='/topic/show?id=325762560c5' target=_blank style='color:#2F92EE;'>#检测试剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62560, encryptionId=325762560c5, topicName=检测试剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sat Mar 13 02:10:54 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301709, encodeId=999c1301e0961, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Mon Mar 30 05:10:54 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429249, encodeId=b84814292492e, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Mon Mar 30 05:10:54 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491093, encodeId=8cd2149109315, content=<a href='/topic/show?id=db91e095978' target=_blank style='color:#2F92EE;'>#病毒检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70959, encryptionId=db91e095978, topicName=病毒检测)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Mon Mar 30 05:10:54 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027578, encodeId=b1ec102e5785a, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Mar 28 17:10:54 CST 2020, time=2020-03-28, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2027147, encodeId=d5ef202e147d0, content=<a href='/topic/show?id=b0bf5808689' target=_blank style='color:#2F92EE;'>#新冠肺炎病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58086, encryptionId=b0bf5808689, topicName=新冠肺炎病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c64275, createdName=piaojinhua, createdTime=Tue Feb 23 13:10:54 CST 2021, time=2021-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934660, encodeId=61e7193466056, content=<a href='/topic/show?id=325762560c5' target=_blank style='color:#2F92EE;'>#检测试剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62560, encryptionId=325762560c5, topicName=检测试剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sat Mar 13 02:10:54 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301709, encodeId=999c1301e0961, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Mon Mar 30 05:10:54 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429249, encodeId=b84814292492e, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Mon Mar 30 05:10:54 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491093, encodeId=8cd2149109315, content=<a href='/topic/show?id=db91e095978' target=_blank style='color:#2F92EE;'>#病毒检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70959, encryptionId=db91e095978, topicName=病毒检测)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Mon Mar 30 05:10:54 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027578, encodeId=b1ec102e5785a, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Mar 28 17:10:54 CST 2020, time=2020-03-28, status=1, ipAttribution=)]
    2020-03-28 公卫新人

    新冠肺炎,疫情何时才能消失

    0

相关资讯

12月1日起,全面实施药品上市许可持有人制度,临床试验机构备案管理,取消药品GMP、GSP认证

《中华人民共和国药品管理法》(以下称药品管理法)已由第十三届全国人大常委会第十二次会议于2019年8月26日修订通过,自2019年12月1日起施行。国家药监局正在抓紧开展配套规章、规范性文件和技术指南的制修订工作,并将按程序陆续发布。

国家药监局关于修订双黄连颗粒等口服制剂处方药和非处方药说明书的公告(2020年 第40号)

  根据药品不良反应评估结果,为进一步保障公众用药安全,国家药品监督管理局决定对双黄连颗粒等口服制剂(包括颗粒剂、糖浆剂、片剂、泡腾片、分散片、咀嚼片、含片、合剂、滴丸、硬胶囊、软胶囊、滴剂)说明书【

国家药监局印发药品质量抽查检验管理办法

各省、自治区、直辖市药品监督管理局,新疆生产建设兵团药品监督管理局,中国食品药品检定研究院: 为加强药品监督管理,规范药品质量抽查检验工作,国家药监局组织修订了《药品质量抽查检验管理办法》,现印发给你们,请遵照执行。

国家药监局:取消这16项证明事项

7月24日,据国家药监局网站消息,根据《国务院办公厅关于做好证明事项清理工作的通知》(国办发〔2018〕47号)要求,为进一步减证便民、优化服务,国家药品监督管理局决定取消16项证明事项。自发布之日起,附件所列证明事项停止执行。根据《国务院办公厅关于做好证明事项清理工作的通知》(国办发〔2018〕47号)要求,为进一步减证便民、优化服务,国家药品监督管理局决定取消16项证明事项(详见附件),现予以

国家药监局:对临床急需短缺药、儿童用药等优先审批

“对临床急需的短缺药、防治重大传染病和罕见病等疾病的新药、儿童用药开设绿色通道,优先审评审批。”国家药品监督管理局政策法规司司长刘沛今天谈及新修订的药品管理法时如是说。

国家药监局批准我国首台自主知识产权碳离子治疗系统获批上市,应用于实体肿瘤治疗

2019年9月29日,国家药品监督管理局经审查,批准兰州科近泰基新技术有限责任公司的“碳离子治疗系统”医疗器械注册。

Baidu
map
Baidu
map
Baidu
map